ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 241 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $23,565,000 | +43.0% | 345,523 | +32.0% | 0.74% | -13.6% |
| Q2 2020 | $16,481,000 | -47.6% | 261,808 | -65.1% | 0.86% | -66.9% |
| Q1 2020 | $31,467,000 | -35.3% | 749,217 | -30.0% | 2.58% | +11.6% |
| Q4 2019 | $48,627,000 | -53.2% | 1,070,616 | -52.9% | 2.32% | -24.6% |
| Q3 2019 | $103,968,000 | -3.0% | 2,271,536 | +24.2% | 3.07% | +50.8% |
| Q2 2019 | $107,198,000 | -26.5% | 1,828,378 | -43.8% | 2.04% | -36.9% |
| Q1 2019 | $145,932,000 | +24.3% | 3,255,230 | +8.0% | 3.22% | +3.4% |
| Q4 2018 | $117,421,000 | -6.5% | 3,014,672 | +10.4% | 3.12% | +69.6% |
| Q3 2018 | $125,614,000 | +140.7% | 2,729,555 | +128.1% | 1.84% | +125.2% |
| Q2 2018 | $52,184,000 | – | 1,196,891 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 4,190,000 | $321,918,000 | 5.54% |
| Prosight Management, LP | 145,700 | $11,194,000 | 5.17% |
| Integral Health Asset Management, LLC | 200,000 | $15,366,000 | 4.57% |
| Copernicus Capital Management, LLC | 3,740 | $287,000 | 4.47% |
| GREAT POINT PARTNERS LLC | 345,120 | $26,516,000 | 4.31% |
| Asymmetry Capital Management, L.P. | 101,245 | $7,779,000 | 3.55% |
| First Light Asset Management, LLC | 321,967 | $24,737,000 | 1.83% |
| DAFNA Capital Management LLC | 76,815 | $5,902,000 | 1.76% |
| SECTORAL ASSET MANAGEMENT INC | 320,059 | $24,590,000 | 1.73% |
| Nicholas Investment Partners, LP | 276,633 | $21,254,000 | 1.64% |